FLX475 in Combination With Ipilimumab in Advanced Melanoma
Clinical trial NCT04894994 · TERMINATED
Trial details
- NCT number
- NCT04894994
- Sponsor
- RAPT Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2022-09-13
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.